Targeted activation of JAK/STAT signalling molecules using specific STAT1, 3 and 5 activators (IFNγ, IL-6 and GM-CSF, respectively) demonstrated the same level of pathway activation in control and HD monocytes, indicating normal function of the signalling cascade in primary human HD immune cells upon stimulation. This evidence concerns the gene IFNG and Huntington disease.